Founded Date: 2020
Last Funding Type: Series A
Headquarters: United States
Investors Number: 13.0
Technology: Biotechnology, Machine Learning
Employee Number: 1-10
Industry: Early Drug Development
Estimated Revenue: 17
Last Funding Date: 2022-09-07
Funding Status: Early Stage Venture
Total Funding: 20350000.0